DRI/EAR Trademark

Trademark Overview

On Thursday, August 28, 2014, a trademark application was filed for DRI/EAR with the United States Patent and Trademark Office. The USPTO has given the DRI/EAR trademark a serial number of 86379962. The federal status of this trademark filing is REGISTERED AND RENEWED as of Sunday, September 14, 2025. This trademark is owned by Pfeiffer Pharmaceuticals, Inc.. The DRI/EAR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention of ear inflammation
dri/ear

General Information

Serial Number86379962
Word MarkDRI/EAR
Filing DateThursday, August 28, 2014
Status800 - REGISTERED AND RENEWED
Status DateSunday, September 14, 2025
Registration Number4734590
Registration DateTuesday, May 12, 2015
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 24, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention of ear inflammation
Pseudo MarkDRY/EAR

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 10, 2014
Primary Code005
First Use Anywhere DateWednesday, April 21, 1976
First Use In Commerce DateWednesday, April 21, 1976

Trademark Owner History

Party NameS.S.S. CO.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressATLANTA, GA 30315-4447
Party NamePfeiffer Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressAtlanta, GA 303024447
Party NamePfeiffer Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAtlanta, GA 303024447
Party NamePfeiffer Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAtlanta, GA 303024447

Trademark Events

Event DateEvent Description
Thursday, September 11, 2014NOTICE OF PSEUDO MARK E-MAILED
Monday, September 1, 2014NEW APPLICATION ENTERED
Wednesday, September 10, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, January 3, 2015EXAMINERS AMENDMENT E-MAILED
Thursday, December 11, 2014ASSIGNED TO EXAMINER
Friday, December 19, 2014TEAS VOLUNTARY AMENDMENT RECEIVED
Friday, December 19, 2014PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Saturday, December 20, 2014EXAMINERS AMENDMENT -WRITTEN
Saturday, December 20, 2014EXAMINERS AMENDMENT E-MAILED
Saturday, December 20, 2014NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, December 22, 2014ASSIGNED TO LIE
Wednesday, December 24, 2014EXAMINER'S AMENDMENT ENTERED
Saturday, January 3, 2015EXAMINERS AMENDMENT -WRITTEN
Saturday, January 3, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Saturday, January 3, 2015EXAMINER'S AMENDMENT ENTERED
Sunday, April 18, 2021TEAS SECTION 8 & 15 RECEIVED
Saturday, January 3, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 21, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, February 4, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 24, 2015PUBLISHED FOR OPPOSITION
Tuesday, February 24, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 12, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, May 12, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Saturday, August 14, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sunday, May 12, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, April 30, 2025AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, May 15, 2025TEAS SECTION 8 & 9 RECEIVED
Sunday, September 14, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sunday, September 14, 2025REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Sunday, September 14, 2025REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Sunday, September 14, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Saturday, August 14, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Saturday, August 14, 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

Related Keywords

inflammation prevention preparations pharmaceutical